Owner only: item control page
EGFR, PTEN, and survivin expression in pre- and posttherapeutic specimens does not predict a clinical benefit from preoperative chemoradiation with cetuximab in patients (pts) with locally advanced rectal cancer (LARC).
Dellas, K., Roedel, F., Arnold, D., Kappler, M., Hipp, M., Bataille, F., Vordermark, D., Roedel, C. and Hartmann, A. (2010) EGFR, PTEN, and survivin expression in pre- and posttherapeutic specimens does not predict a clinical benefit from preoperative chemoradiation with cetuximab in patients (pts) with locally advanced rectal cancer (LARC). Journal of Clinical Oncology 28 (15_sup), p. 3653.Date of publication of this fulltext: 19 Dec 2024 11:36
Article
Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | Journal of Clinical Oncology | ||||
| Publisher: | AMER SOC CLINICAL ONCOLOGY | ||||
|---|---|---|---|---|---|
| Place of Publication: | ALEXANDRIA | ||||
| Volume: | 28 | ||||
| Number of Issue or Book Chapter: | 15_sup | ||||
| Page Range: | p. 3653 | ||||
| Date | 2010 | ||||
| Institutions | Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie) | ||||
| Identification Number |
| ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 66116 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric